Latest Non Dilutive Funding News

Argenica Therapeutics reports ARG-007 is safe in acute ischemic stroke patients and shows promising efficacy signals in a high-risk subgroup, paving the way for a focused Phase 2b trial.

Thor Energy reported a transformative quarter with standout natural hydrogen and helium exploration results at its HY-Range Project, alongside significant asset sales that strengthen its financial position.

Firebird Metals has advanced its manganese-rich battery materials strategy with new Chinese patents, a significant kiln sales interest, and a A$6 million capital raise, alongside key leadership changes.

Kuniko Limited has executed a binding earn-in agreement for a major Australian gold-silver project and raised A$2.7 million to fund exploration, while progressing its Norwegian battery metals portfolio.

Revolver Resources has completed a key drilling program at its Dianne Copper Mine Project, affirming resource estimates and progressing towards a targeted production restart in late 2026. The company also secured significant funding to support upcoming development milestones.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Locksley Resources has made significant strides in its US critical minerals strategy, advancing proprietary antimony refining technology and expanding its Mojave Project landholding. The company also completed an oversubscribed capital raise to fund upcoming drilling and downstream processing initiatives.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.

First Au Limited has struck a deal granting AustChina Holdings an exclusive 19-month option to acquire its Eastern Victorian Goldfield Project, unlocking value from a non-core asset while sharpening focus on its African and Western Australian ventures.

IRIS Metals Limited has made substantial progress in its South Dakota lithium projects, completing critical drilling phases and expanding its land holdings through strategic acquisitions, supported by a recent $4.27 million capital raise.

Iondrive Limited has joined a €3.1 million European battery recycling consortium backed by a German government grant, aiming to establish a closed-loop supply chain using its innovative DES technology.